FROM IDEA TO INNOVATION

acib has built up a network of numerous small, middle and large sized industry partners coming from several sectors of industrial biotechnology. Most of them joined the COMET consortium, but – as COMET is temporary and monetary limited – acib also has opportunities for alternate collaboration possibilities. An attractive offer for our stakeholders from industry is the academic partner network, which allows industrial organizations to consume R&D activities from a tailored research expertise portfolio coming from currently 53 scientific partners.

acib AS TARGETED-RESEARCH-HUB

acib’s position as a targeted-research-hub for industrial biotechnology will be further developed. In combining all partners and networks in a new contractual acib partner network, acib is able to fulfill its mission of connecting the worlds from academia and industry for innovation and science-know-how. Thus acib is a one-stop-shop and ideal partner for Open Innovation.

CURRENT OFFERS – RESEARCH MARKET PLACE

acib offers new technologies, expertise and project concepts. Please keep up-to-date with our latest offers by subscribing to our newsletter. For further information please contact Martin Trinker.

 

38 / PROJECT OFFER

Enzyme discovery and development for polymer processing


13.12.2017

view offer

37 / PROJECT OFFER

3D Phase Contrast Microscopy for Flow Cytometry


13.12.2017

view offer

36 / PROJECT OFFER

Improving the immunogenicity of vaccines


13.12.2017

view offer

35 / TECHNOLOGY OFFER

Up-regulation of protein expression through use of RNA polymerase binding aptamers (RAPS)


21.11.2017

view offer

34 / PROJECT OFFER

Making nanoparticles more stable for biological environments


20.11.2017

view offer

33 / SERVICE OFFER

Smart library approaches employing the BioXPTM 3200 platform


13.11.2017

view offer

32 / PROJECT OFFER

Bacterial Natural Product Optimization via Biosynthetic Engineering and Medicinal Chemistry


13.06.2017

view offer

31 / PROJECT OFFER
Project on Antibacterial Antibiotic Discovery and Development


13.06.2017

view offer

30 / CO-DEVELOPMENT OFFER
Inhibition of gene expression from “foreign DNA”


13.06.2017

view offer

29 / PROJECT OFFER
BioF&F – Biotechnological production of Flavor & Fragrance compounds


30.03.2017

view offer

28 / PROJECT OFFER
BOSS – Biotechnological Optimizations by Selection Systems


29.03.2017

view offer

27 / PROJECT OFFER
Biocatalytic methylation and demethylation of phenol derivatives


24.03.2017

view offer

26 / PROJECT OFFER
Lactic Acid Production

view offer

25 / PROJECT OFFER
Biorefinery Solutions
10.03.2017

view offer

24 / PROJECT OFFER
Photo-BioPolymers


10.03.2017

view offer

23 / CO-DEVELOPMENT OFFER
GISS – Gastro Intestinal Simulation System


view offer

22 / TECHNOLOGY OFFER
Compact and optimized metabolic pathway design in yeasts


16.02.2017

view offer

21 / SERVICE OFFER
Assembly of multi-part DNA constructs


26.01.2017

view offer

20 / SERVICE OFFER
Metabolomics


19.01.2017

view offer

19 / SERVICE OFFER
13-C labeled metabolite extract


19.01.2017

view offer

18 / PROJECT OFFER
Towards the next generation of industrial bioethanol production


19.01.2017

view offer

17 / PROJECT OFFER
Project offer: Towards the Next Generation of Lignocellulose-Based Industrial Biomanufacturing


19.01.2017

view offer

16 / PROJECT OFFER
Biotechnological synthesis of natural insect repellents


17.01.2017

view offer

15 / PROJECT OFFER
Continuous biocatalysis using liquid membrane technology


13.12.2016

view offer

14 / SERVICE OFFER
Bioinformatics


13.12.2016

view offer

13 / COMPETENCE OFFER
Biocatalytic Synthesis and Enzyme Technology


18.11.2016

view offer

12 / PROJECT OFFER
Enzymatic Alkene Cleavage


28.10.2016

view offer

11 / PROJECT OFFER
Biotechnological preparation of chitin and chitosan from shrimp shell waste


25.10.2016

view offer

10 / TECHNOLOGY OFFER
3D Enzyme Search


view offer

9 / PROJECT OFFER
Synthesis of bio-based resveratrol analogues


23.08.2016

view offer

8 / PROJECT OFFER
Combinatorial pathway assembly for Green Chemistry


26.07.2016

view offer

7 / SERVICE OFFER
Directed modification of proteins using unnatural amino acids


26.07.2016

view offer

6 / CO-DEVELOPMENT OFFER
Drug Resistance


18.07.2016

view offer

5 / TECHNOLOGY OFFER
Novel Hydroxynitrile Lyases


05.07.2017

view offer

4 / PROJECT OFFER
Antibacterial Antibiotic Discovery and Development – AntiBac


20.06.2016

view offer

3 / PROJECT OFFER
Bacterial Natural Product Optimization via Biosynthetic Engineering and Medicinal Chemistry – BacTech


1.06.2016

view offer

2 / TECHNOLOGY OFFER
Biocatalytic Friedel-Crafts Acylations


25.05.2016

view offer

1 / TECHNOLOGY OFFER
Nanomembranes


11.02.2016

view offer

  • “Our research and development progress would have been impossible without the collaboration with acib. acib complements our expertise to create a world class laboratory that can execute experiments at a high level. And, when we go to share results, acib’s stellar reputation ensure others have confidence in our data.”

    Edward Eveleth / Chairman HocusLocus

  • “We are working with acib since 2012. The results are exceeding our expectations and thus increase our competitiveness in the international biotechnology-market. We value the high competence and expertise of acib scientists, as well as the open and constructive discussions marked by trust and leading to pioneering innovations.”

    Otto Kanzler / CEO Chorus

  • “acib facilitates in a highly professional and efficient manner the collaboration of people from two different worlds, academia and business. Knowing the different mindsets from both sides, acib is a valuable partner in helping to translate the needs and visions of both company and academic partners into a successful joint R&D cooperation.”

    Gerald Ruppert / IP Manager Viscose Faser

  • “Teaming up with acib has allowed us to be active at the cutting edge of CHO Cell Engineering and we are delighted to work with a highly devoted and skilled team with the aim to reduce future production costs for therapeutic proteins.”

    Daniel Ivansson / Research Engineer Strategic Technologies GE Healthcare

  • “Thanks to acib we keep in touch with recent developments in a field of key relevance for our products.”

    Dr. Dieter Moll / Research Director Biomin

  • “We joined our sister company AB Enzymes to collaborate with the acib teams from the Technical University of Vienna and BOKU and benefit from their renowned expertise in Trichoderma. Although at an early stage we are confident this collaboration will be fruitful for both sides.”

    Dr. Jari Vehmaanperä / Global Head R&D Roal Oy

  • “acib is a very important R&D partner for Clariant Group Biotechnology in the field of academic cooperation and was chosen because of its specific expertise in Clariant’s fields of interest and current activities. acib provides research expertise which is at the forefront of experimental R&D state of the art, enabling up-to-date research work. acib has broad expertise in various fields of industrial biotechnology (strategic fit to industry needs).”

    Dr. Georg Schirrmacher / Scientific Coordinator Clariant

  • “As a pretty young company in the field of biolife-science we appreciate the close cooperation with the absolute experts of acib”

    Peter Pucher / Head of R&D BDI – BioLife Science

  • “We are pleased with the long-lasting collaboration with acib. The open and creative atmosphere and the in general excellent results obtained have over the years contributed to the successful implementation of several industrial process in the production of chemical intermediates at DSM.”

    Dr. Martin Schürmann / Principal Scientist DSM

  • “The current cooperation with acib provides an essential and valuable contribution to improve our existing manufacturing process. The theoretical and practical knowledge provided by acib are key parameters that will bring our joint project to success. ”

    Dr. Matthias Müllner / Head of Manufacturing Themis Bioscience

  • “While having grown to a large organization, acib still provides a highly professional and responsive collaborative research environment capable of quickly reacting to specific project needs.”

    Dr. Peter Pöchlauer / Patheon Austria GmbH & Co KG

  • “The acib collaboration provides an important contribution to Sandoz’s new technology evaluation & development programs.”

    Dr. Sascha Keller / Head of Downstream Process Developement Sandoz

  • “acib is the foundation of our collaboration strategy in Austria.  The projects we undertake within the framework in both Vienna/Tulln and Graz are essential to our innovation strategy.  The quality and continuity of the programs are first rate while the overall context and connectivity that one experiences in parallel add a great deal to the experience.”

    Michael Burnet / Managing Director Synovo

  • “acib stands out due to the huge pool of multidisciplinary expertise and capabilities available for its industrial partners across the entire field of industrial biotechnology”

    Dr. Thomas Purkarthofer / Head of Business Development Validogen (formerly VTU Technology)

  • “acib provides the right mix of scientific competence, goal-oriented flexibility and variety of specialist skills to perform ambitious research projects with both fundamental and application aspects in a fast and effective manner.”

    Jürgen Felber / CEO IPUS

  • “Our acib partners … are doing a thorough work. They pursue the project with diligence and a good sense for focusing on the important issues to be solved. It is a pleasure to collaborate with such a competent team and see continuous progress in achieving the project’s goals.”

    Dr. Judith Wahrheit / Contract Research Biocrates

  • “The close and trusting collaboration with acib’s academic partners is a constant source of new and valuable stimulus for the development of innovative metabolic pathways and novel reactor designs for optimal performance of the functionalization of alkanes.”

    Bastian Grund / Project Manager Evonik

  • “The acib collaboration enables rapid and straight-forward research on current requirements of the Roombiotic product pipeline. I personally recommend acib to biotech start-ups as powerful and reliable partner in challenging research projects.“

    Dr. Daniel Treffer / CEO Roombiotic

  • “Our collaboration with acib has so far proven to be very productive and has resulted in a number of exciting technical applications. The scientific team members are highly qualified and really motivated to pursue their objectives.”

    Dr. Christa Tauer / Head of Bio OpU Process Development Shire

  • “The collaboration with acib and its constituting body of experts in biotechnology in the framework of a funded R&D competence centre enables us to engage in high-risk potentially high-reward research. We greatly appreciate this opportunity.”

    Dr. Patrick Lorenz / Head of Molecular Biology AB Enzymes